nach oben

Clinical Pharmacokinetics

Erschienen in:

13.03.2021 | Letter to the Editor

Authors’ Reply to Völler et al: “Comment on: Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II”

verfasst von: Khaled Abduljalil, Xian Pan, Amita Pansari, Masoud Jamei, Trevor N. Johnson

Erschienen in: Clinical Pharmacokinetics | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Völler S, Flint RB, Simons SHP, Knibbe CAJ. Comment on: “Preterm physiologically based pharmacokinetic model, part I and part II”. Clin Pharmacokinet. 2021;. https://doi.org/10.1007/s40262-021-00993-4.CrossRefPubMed

Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. A preterm physiologically based pharmacokinetic model. Part I: physiological parameters and model building. Clin Pharmacokinet. 2020;59(4):485–500.CrossRef

Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. Preterm physiologically based pharmacokinetic model. Part II: applications of the model to predict drug pharmacokinetics in the preterm population. Clin Pharmacokinet. 2020;59(4):501–18.CrossRef

Salem F, Johnson TN, Hodgkinson ABJ, Ogungbenro K, Rostami-Hodjegan A. Does, “birth” as an event impact maturation trajectory of renal clearance via glomerular filtration? Reexamining data in preterm and full-term neonates by avoiding the creatinine bias. J Clin Pharmacol. 2021;61(2):159–71.CrossRef

Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24(1):67–76.CrossRef

Shimada S, Kasai T, Konishi M, Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr. 1994;125(2):270–7.CrossRef

DeKoninck P, Steenhaut P, Van Mieghem T, Mhallem M, Richter J, Bernard P, et al. Comparison of Doppler-based and three-dimensional methods for fetal cardiac output measurement. Fetal Diagn Ther. 2012;32(1–2):72–8.CrossRef

Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, et al. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos. 2002;30(8):883–91.CrossRef

Neeli H, Hanna N, Abduljalil K, Cusumano J, Taft D. Application of physiologically based pharmacokinetic-pharmacodynamic modeling in preterm neonates to guide gentamicin dosing decisions and predict antibacterial effect (submitted).

Titel: Authors’ Reply to Völler et al: “Comment on: Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II”
verfasst von: Khaled Abduljalil
Xian Pan
Amita Pansari
Masoud Jamei
Trevor N. Johnson
Publikationsdatum: 13.03.2021
Verlag: Springer International Publishing
Erschienen in: Clinical Pharmacokinetics / Ausgabe 5/2021
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI: https://doi.org/10.1007/s40262-021-00995-2

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents

Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic Analysis

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor

Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action?

Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis

Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effect of Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan Given in Combination